Generic Name and Formulations:
Formulated bovine type I collagen (2.6%); topical gel.
Taxus Cardium Pharmaceuticals Group
Indications for EXCELLAGEN:
Management of wounds including: partial and full- thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/graft, post-Moh’s surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns and skin tears) and draining wounds.
Adults and Children:
See literature. Perform debridement or excision prior to application. Apply a thin layer directly to the entire wound surface and edges. May be occluded with non-adherent, gauze and foam dressings; change dressings and reevaluate weekly. If healing is incomplete, gel may be reapplied; max once weekly.
Control excessive exudate, excessive bleeding, acute swelling, and/or infection before starting treatment. Discontinue or remove if infections, chronic inflammation, allergic reaction, excessive redness, pain, swelling occur. Do not freeze or reuse syringes. Avoid exposure to high temperature.
Wound care device.
Local reactions (eg, infections, inflammation, swelling).
Kit—1 (4 pre-filled, single-use [0.5mL] syringes w. applicators)
Renal and Urology News Articles
- Surgery, Radiation Regimens for High-Grade PCa Offer Similar Outcomes
- Molecular Subtypes Linked to Outcomes in Acute Kidney Injury
- AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides
- AHA: Dapagliflozin Noninferior to Placebo for MACE in T2DM
- Health Information Breach Brings Record Settlement
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)